It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Stablecoins can play a strategic role in liquidity and risk management. This short intro explains when to hold stablecoins in a portfolio for balance and flexibility.
18,427 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Depreciation has long been a powerful tool for real estate investors. This piece unpacks the idea behind trump floats...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
When a company executive moves tens of thousands of shares, it sparks questions. This guide explains what insider sel...
A founder sold a meaningful chunk of stock, but does that signal trouble or a routine liquidity move? This article br...
This in-depth look examines the factors behind wallbox (wbx) 2025 earnings and what they mean for investors. Learn ab...
Defiance’s 2X inverse ETF tied to SMCI confronts a classic risk now that SMCI has reported after hours. The fund’s da...
Micron Technology stock sits at the crossroads of AI memory demand and a broader semiconductor pullback. This guide w...
August could bring more shares to the market as insiders unlock. This article breaks down what spacex's lockup starts...
Orion Group stock dropped experienced intraday swings, illustrating how earnings, guidance, and market sentiment can ...
Bold moves in the logistics space are reshaping Amazon’s growth story. This article breaks down what the latest annou...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...